J&J Aims to Expand in Multiple Myeloma With First Drug for Novel Target Posted on December 11, 2022December 16, 2022 by Frank Vinluan Johnson & Johnson is seeking FDA approval of a multiple myeloma drug that could […] Post navigation STAT+: Novartis develops CAR-T therapy that can be made in a fraction of the standard timeLow Nutritional Quality In Vegetarian Meat Substitutes Leave a Reply Cancel replyYou must be logged in to post a comment.
